Mirae Asset Global ETFs Holdings
IRWD icon

Mirae Asset Global ETFs Holdings’s Ironwood Pharmaceuticals IRWD Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$394K Buy
93,191
+3,082
+3% +$11.9K ﹤0.01% 2124
2026
Q1 		$312K Buy
90,109
+12,006
+15% +$49.2K ﹤0.01% 2125
2025
Q4 		$263K Buy
78,103
+5,132
+7% +$13.3K ﹤0.01% 2220
2025
Q3 		$95.6K Sell
72,971
-14,464
-17% -$15K ﹤0.01% 2682
2025
Q2 		$62.7K Buy
87,435
+3,339
+4% +$2.62K ﹤0.01% 2823
2025
Q1 		$124K Sell
84,096
-5,780
-6% -$13.8K ﹤0.01% 2534
2024
Q4 		$398K Sell
89,876
-3,384
-4% -$13.7K ﹤0.01% 2036
2024
Q3 		$383K Buy
93,260
+8,829
+10% +$47.5K ﹤0.01% 2046
2024
Q2 		$546K Buy
+84,431
New +$597K ﹤0.01% 1780

Other funds holding IRWD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Mirae Asset Global ETFs Holdings's IRWD Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its Ironwood Pharmaceuticals (IRWD) stake by 3.4% in Q2 2026, buying an estimated $11.9K and bringing the position to 93,191 shares worth $394K. The position accounts for ﹤0.01% of the portfolio, ranked #2124.

Mirae Asset Global ETFs Holdings first reported a position in IRWD in Q2 2024 and has held it in 9 quarters since. The position peaked at $546K in Q2 2024. 212 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 93,191 shares of Ironwood Pharmaceuticals worth $394K as of Q2 2026.
  • Mirae Asset Global ETFs Holdings bought 3,082 Ironwood Pharmaceuticals shares in Q2 2026, an estimated $11.9K.
  • Ironwood Pharmaceuticals made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #2124 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Ironwood Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
  • Mirae Asset Global ETFs Holdings's Ironwood Pharmaceuticals position peaked at $546K in Q2 2024.
  • 212 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.